Capricor Therapeutics, Inc. (CAPR)
33.48
-0.90
(-2.62%)
USD |
NASDAQ |
May 07, 10:58
Capricor Therapeutics SG&A Expense (TTM) : 23.69M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 32.68M |
| Repligen Corp. | 219.25M |
| Vaxart, Inc. | 17.61M |
| Penumbra, Inc. | 663.42M |
| Allogene Therapeutics, Inc. | 56.78M |